​Bladder cancer presents a clinical challenge, which requires multi-disciplinary efforts. Improvement in survival rate might be seen with improved preventive measures, earlier detection, as well as development of new therapeutic strategies to improve local control and to combat unrecognized micrometastases.

The most common histology is transitional cell carcinoma. Muscle-invasive bladder cancer often demands multi-disciplinary consideration and suitable cases may be referred to Urology Conference.​